FACTBOX- The race for a coronavirus vaccine

 (Adds IDT Biologika; updates AstraZeneca, Russia vaccine, Johnson & Johnson)
    Oct 14 (Reuters) - More than 150 potential vaccines are being developed and tested globally to stop the COVID-19 pandemic,
with 42 in human trials, according to the World Health Organization (WHO). 
    The following list tracks the latest developments from major drugmakers and research institutes that have started human
trials for their vaccine candidates:
    For a separate FACTBOX on treatments under development, click
 Company                      State of play                                        Development phase 
 Not applicable               Late-stage trial of the Sputnik V vaccine,           Vaccine, approved in Russia, produced
                              developed by Moscow's Gamaleya Research Institute,   antibody response in all participants in
                              is underway in Moscow                                early-stage trials            
 Not applicable               A second Russian vaccine, developed by Vector        Early-stage trial             
                              Institute in Siberia, was granted regulatory         
                              approval in the country on Oct. 14.                  
 AstraZeneca                  A U.S. trial of the British drugmaker's vaccine      Late-stage trials             
                              candidate has been on pause since Sept. 6, after a   
                              patient fell ill in a separate study. Trials         
                              elsewhere have resumed.                              
 Sinopharm                    Developing two vaccines, one of which has shown      UAE grants emergency approval; late-stage
                              promise in humans                                    trials in Bahrain ongoing 
 Pfizer         and BioNTech  Vaccine produced virus-neutralizing antibodies in    Expects late-stage data in October, plans to
 SE                           early-stage trials                                   submit for approval immediately              
 Moderna Inc                  On track to produce 20 million doses by year-end     30,000-subject final stage trial began on
                                                                                   July 27             
 Sinovac Biotech              CoronaVac approved for emergency use in China to     Launched final-stage trial in Indonesia
                              vaccinate high-risk groups                                       
 CanSino Biologics            Early results showed vaccine is safe                 Late-stage trials have begun in Russia
 Inovio Pharma                U.S. health regulator pauses company's plans to      Company aims to respond to FDA's queries in
                              start final trials as agency seeks more information  October             
 Chongqing Zhifei Biological  Unit Anhui Zhifei Longcom Biopharmaceutical has      Mid-stage trial             
 Products                     begun human trials                                   
 Bharat Biotech               Vaccine approved for human trials in India           Early- to mid-stage trials             
 Johnson & Johnson            Vaccine trials were paused on Oct. 12 as the         A 60,000-person late-stage study has
                              company is reviewing a case of unexplained illness   begun            
                              in a study volunteer                                 
 Novavax                      Has begun late-stage study (10,000 volunteers) in    Late-stage study began in UK             
                              UK; Aims to start another late-stage trial with      
                              30,000 people in U.S. in October                     
 GlaxoSmithKline              Partnered with Sanofi           to develop a         Early-mid stage trials to begin in September
 CureVac                      German biotech expects data in September/October     Mid-stage trial             
 Clover Biopharmaceuticals    Chinese developer received $66 mln from an epidemic  Early-stage trials             
                              response group                                       
 Not applicable               Scientists at Imperial College London running        Early-stage trials             
 Genexine                     South Korean company has begun human trials          Early-stage trials             
 Not applicable               Institute of Medical Biology at Chinese Academy of   Mid-stage trials             
                              Medical Sciences testing a vaccine                   
 Walvax Biotechnology         Trials sponsored by Walvax and a Chinese military    Mexico to conduct late-stage trials
                              research institute, have begun                                   
 Medicago                     Studying a plant-based vaccine                       Early-stage trials             
 Cadila Healthcare            Plans to finish late-stage trials by early 2021      Early-stage trials             
 Not applicable               University of Queensland began human trials with     Early-stage testing (
                              Australia's CSL         .                            
 Arcturus Therapeutics        Dosed first group of participants                    Early-stage testing             
          and Duke-NUS                                                             
 Osaka University, AnGes,     Trial in 30 healthy volunteers                       Early-stage testing (
 Takara Bio                                                                        
 Kentucky Bioprocessing       British American Tobacco          unit expects to    Early-stage testing planned (
                              begin trial in 180 adults                            
 Vaxine Pty/Medytox           Expects to start mid-stage trials                    Early-stage testing             
 Medigen Vaccine Biologics    Study in 45 people                                   Early-stage trial (
 Merck & Co                   Expects to begin human trials later this year        Early-stage trial planned             
 ReiThera/Leukocare/Univerce  Collaborating on a potential shot                    Early-stage trial (
 Not applicable               Cuba's Instituto Finlay de Vacunas begins            Early-stage trial (
                              early-stage trials in 676 participants               
 Themis BIO/Institute         Merck's unit started early-stage study in 90 people  Early-stage trial (
 Pasteur/University of        in collaboration with Institute Pasteur              
 Pittsburg CVR                                                                     
 Research Institute for       Studying QazCovid-in in healthy volunteers           Early-mid stage trials (
 Biological Safety                                                                 
 Problems, Rep of Kazakhstan                                                       
 West China Hospital,         Testing vaccine candidate in healthy Chinese adults  Early-stage trials (
 Sichuan University                                                                
 Beijing Wantai Biological    Candidate approved by China's National Medical       Early-stage trials (
 Pharmacy/Xiamen University   Products Administration for clinical trials          
 COVAXX                       Brazilian hospital group DASA to conduct             Early-stage trials in Taiwan             
                              mid/late-stage trials                                
 University Hospital          To begin early stage trials in adults                Early-stage studies (
 Institute of Biotechnology,  Began early-stage studies of vaccine candidate in    Early-stage studies (
 Academy of                   168 participants                                     
 Military Medical Sciences,                                                        
 PLA of China                                                                      
 Germany's IDT Biologika      The company's vaccine, developed along with German   Early-stage trial             
                              Centre for Infection Research, has received          
                              clearance to be tested in humans.                    
 (Reporting by Vishwadha Chander and Manas Mishra in Bengaluru; Editing by Shounak Dasgupta, Sriraj Kalluvila, Maju Samuel and
Ramakrishnan M.)